Jiangsu Hengrui reported CNY2.28B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Sh Fosun Pharma CNY 870.83M 23.56M Mar/2026
Sh Pharmaceutical CNY 577.49M 110.71M Dec/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Wuxi Apptec CNY 4.65B 2.42B Mar/2026
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026